NeviMed
Full-body Imaging for Dermatology
Company Overview
Snapshot
Founded in March 2015 by Uri Shkolnik, NeviMed operates with 1–10 employees. The company's status changed to Non Active in May 2023, indicating it ceased operations.
Business overview
NeviMed develops the DermoScout, a full-body skin scanner designed for monitoring various abnormal skin conditions. This device integrates advanced algorithms for comparing, tracking, screening, and diagnosing multiple dermatological phenomena. Initially, the DermoScout's algorithms focus on melanoma screening, aiming to support dermatologists by identifying false signs or symptoms and reducing examination times to under six minutes. The company targets the healthcare sector, specifically providers like dermatologists, clinics, and hospitals, by offering solutions in medical devices, diagnostics, and non-invasive scanning technologies.
Log in to access full profile ›Company Intelligence Q&A
- What is NeviMed's primary product?
- NeviMed's primary product is the DermoScout, a full-body skin scanner equipped with advanced algorithms for monitoring and diagnosing abnormal skin conditions, with an initial focus on melanoma screening.
- When was NeviMed founded?
- NeviMed was founded in March 2015.
- What is the current operational status of NeviMed?
- NeviMed is currently Non Active, having ceased operations in May 2023.
- Who is the founder of NeviMed?
- Uri Shkolnik is the founder of NeviMed.
- What problem does the DermoScout aim to solve for dermatologists?
- The DermoScout aims to assist dermatologists with patient examinations, identify false signs or symptoms, and reduce examination time to less than six minutes, thereby improving care quality and practice efficiency.